Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols.
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols.
复制标题
DOI:
10.3390/pharmaceutics14091870
复制
发表时间:
2022-09-05
期刊:
影响因子:
5.4
通讯作者:
Mansour HM
中科院分区:
文献类型:
--
作者:
Alabsi W;Eedara BB;Encinas-Basurto D;Polt R;Mansour HM
Central nervous system (CNS) disorders, such as psychiatric disorders, neurodegeneration, chronic pain, stroke, brain tumor, spinal cord injury, and many other CNS diseases, would hugely benefit from specific and potent peptide pharmaceuticals and their low inherent toxicity. The delivery of peptides to the brain is challenging due to their low metabolic stability, which decreases their duration of action, poor penetration of the blood-brain barrier (BBB), and their incompatibility with oral administration, typically resulting in the need for parenteral administration. These challenges limit peptides’ clinical application and explain the interest in alternative routes of peptide administration, particularly nose-to-brain (N-to-B) delivery, which allows protein and peptide drugs to reach the brain noninvasively. N-to-B delivery can be a convenient method for rapidly targeting the CNS, bypassing the BBB, and minimizing systemic exposure; the olfactory and trigeminal nerves provide a unique pathway to the brain and the external environment. This review highlights the intranasal delivery of drugs, focusing on peptide delivery, illustrating various clinical applications, nasal delivery devices, and the scope and limitations of this approach.
登录
查看更多内容
影响因子:
4.6
作者:
Ayoub BM;Mowaka S;Safar MM;Ashoush N;Arafa MG;Michel HE;Tadros MM;Elmazar MM;Mousa SA
通讯作者:
Mousa SA
影响因子:
14.5
作者:
Baier, Paul Christian;Weinhold, Sara Lena;Hinze-Selch, Dunja
通讯作者:
Hinze-Selch, Dunja
影响因子:
5.4
作者:
Bahadur S;Pardhi DM;Rautio J;Rosenholm JM;Pathak K
通讯作者:
Pathak K
影响因子:
5.4
作者:
Alabsi W;Al-Obeidi FA;Polt R;Mansour HM
通讯作者:
Mansour HM
影响因子:
5.4
作者:
Alabsi W;Acosta MF;Al-Obeidi FA;Hay M;Polt R;Mansour HM
通讯作者:
Mansour HM